Heart Disease Trial, Recruiting NCT06994221 Sponsor: RenJi Hospital Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06994221
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 75 years of age.
  • People who have been diagnosed with a heart attack classified as either STEMI or NSTEMI, according to standard cardiology guidelines.
  • The trial aims to enrol an equal number of male and female participants.
  • People who have undergone a procedure to look at the heart's arteries (coronary angiography) and a procedure to open blocked arteries (PCI).
  • People who have had an ultrasound of the heart (echocardiography) or a specialised heart scan (cardiac MRI) used to check for a specific change in the heart wall called a ventricular aneurysm.
  • People who are willing and able to provide written consent to participate.

Who may not be able to join:

  • People under 18 years of age.
  • People who are pregnant or currently breastfeeding.
  • People who have had an allergic reaction to radio tracers (special substances used in certain medical scans) in the past.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13524596108

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 November 2024
Est. completion
31 July 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

FAPI uptake (SUV max); FAPI uptake (SUV mean)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov